Kanso Diagnostics Israeli Company

Kanso diagnostics develop a molecular testing platform for diagnosis of bacterial and viral infections. The company's solution aims to change the contemporary diagnostics experience, and the platform facilitates the at-home medical revolution, ensuring accessibility and ease of use. Kanso's novel technology accurately detects multiple pathogens and genetic biomarkers from a single sample, minimizing diagnosis time-to-results from days to minutes. This proprietary technology offers PCR-grade accuracy and rapid home testing convenience, providing an end-to-end solution for diagnosing bacterial and viral infections, available anywhere and anytime.